Target intelligence / Profile preview

Esterase OVCA2 (OVCA2)

Target
OVCA2
Molecular classification
Enzyme, Serine hydrolase, Esterase, Candidate tumor suppressor
01

Overview

OVCA2 (Esterase OVCA2) is a human metabolic serine hydrolase enzyme that shows strong preference for long-chain, unbranched alkyl ester substrates, catalyzing hydrolysis reactions using a classic catalytic triad (Ser117, Asp179, His206). It is a well-folded, intracellular protein, mainly located in the cytoplasm, and is evolutionarily conserved. OVCA2 is identified as a candidate tumor suppressor in ovarian cancer and potentially serves as a biomarker for disease, with links to cancer proliferation and acetaldehyde remediation noted. While its role in cancer biology is supported by expression and genomic studies, its natural physiological substrates and full biological functions remain incompletely defined. As of current research, no drugs are known to target OVCA2 directly, but its enzymatic mechanism suggests that future inhibitors, as with other serine hydrolases, would act via catalytic triad modulation or inhibition.

Other names
OVCA2 serine hydrolase domain containingOvarian cancer-associated gene 2 proteinCandidate tumor suppressor in ovarian cancer 2Esterase OVCA2OVCA2 serine hydrolase domain-containing proteinOvarian cancer gene-2 proteinOvarian tumor suppressor candidate 2OVCA2
02

Mechanism of action

Enzyme inhibition/modulation (Drugs would likely act via hydrolase inhibition if developed)

03

Biological functions

Hydrolysis of long-chain alkyl estersMetabolismPotential detoxification (acetaldehyde remediation)Putative tumor suppression
04

Disease associations

CancerPossibly related to metabolic diseasePossibly related to acetaldehyde toxicity
05

Biomarkers

Ovarian cancer biomarker

Beyond the preview

Go deeper on Esterase OVCA2 (OVCA2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Esterase OVCA2 (OVCA2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call